News

HARTMANN USA, Inc. announced an exclusive national commercial distribution agreement with SweetBio®, a biotechnology company pioneering bioengineered wound care solutions. Through the agreement, HARTMANN USA will become the exclusive nationwide commercial distribution partner for VERIS™, SweetBio®'s advanced wound care product. VERIS™ is intended for the management of acute and chronic wounds and uniquely features collagen derivative and Mānuka honey in a patented formulation.

We’re proud to share that HARTMANN USA, Inc. has received an Innovative Technology Contract from Vizient® for Zetuvit® Plus and ColActive® PLUS—two solutions designed to support better wound care across diverse care settings. Vizient is one of the largest healthcare group purchasing organization (GPO) in the US.

HARTMANN USA and Corstrata announce their collaboration to support home health and other in-home providers in caring for wound patients at a time when the incidence of complex chronic wounds is increasing while access to wound care nurse specialists is becoming more challenging.